Therapeutic Effects of Short-Term Monochromatic Infrared Energy Therapy on Patients With Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study

被引:15
|
作者
Hsieh, Ru-Lan [1 ,2 ]
Lo, Min-Tzu [3 ]
Lee, Wen-Chung [4 ]
Liao, Wei-Cheng [2 ]
机构
[1] Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei 11101, Taiwan
[2] Taipei Med Univ, Taipei, Taiwan
[3] Natl Taiwan Univ, Inst Epidemiol & Preventat Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan
关键词
International Classification of Functioning; Disability and Health; knee osteoarthritis; monochromatic infrared energy; therapeutic effect; DIABETIC PERIPHERAL NEUROPATHY; OUTCOME SCORE KOOS; HOSPITAL ANXIETY; LIGHT THERAPY; PAIN; VALIDATION; SENSATION; CLASSIFICATION; RELIABILITY; INSTRUMENT;
D O I
10.2519/jospt.2012.3881
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
STUDY DESIGN: Randomized, double-blind, placebo-controlled study. OBJECTIVES: To examine the short-term therapeutic effects of monochromatic infrared energy (MIRE) on participants with knee osteoarthritis (OA). Patients were assessed according to the International Classification of Functioning, Disability and Health. BACKGROUND: MIRE is commonly used in therapy for patients with peripheral neuropathies. However, research has not focused intensively on the therapeutic effects of MIRE in patients with knee OA. METHODS: This study enrolled 73 participants with knee OA. Participants received six 40-minute sessions of active or placebo MIRE treatment (890-nm wavelength; power, 6.24 W; energy density, 2.08 J/cm(2)/min; total energy, 83.2 J/cm(2)) over the knee joints for 2 weeks. International Classification of Functioning, Disability and Health related outcomes were collected weekly over 4 weeks using the Knee injury and Osteoarthritis Outcome Score, Lysholm Knee Scale, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory, Chronic Pain Grade questionnaire, World Health Organization Quality of Life-brief version, and OA Quality of Life Questionnaire. Data were analyzed by repeated-measures analysis of variance. RESULTS: No statistically significant differences were found for the interaction of group by time for Knee injury and Osteoarthritis Outcome Score scores, including pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life. Scores on the Lysholm Knee Scale, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory, Chronic Pain Grade questionnaire, World Health Organization Quality of Life-brief version, and OA Quality of Life Questionnaire also showed no significant differences between the 2 groups at any of the 4 follow-up assessments. CONCLUSION: Short-term MIRE therapy provided no beneficial effects to body functions, activities, participation, and quality of life in patients with knee OA. LEVEL OF EVIDENCE: Therapy, level 1b-.J Orthop Sports Phys Ther 2012;42(11):947-956, Epub 5 September 2012. doi:10.2519/jospt.2012.3881
引用
收藏
页码:947 / 956
页数:10
相关论文
共 50 条
  • [21] Metformin for knee osteoarthritis with obesity: study protocol for a randomised, double-blind, placebo-controlled trial
    Lim, Yuan Z.
    Wang, Yuanyuan
    Urquhart, Donna M.
    Estee, Mahnuma Mahfuz
    Wluka, Anita E.
    Heritier, Stephane
    Cicuttini, Flavia M.
    BMJ OPEN, 2023, 13 (12):
  • [22] A Randomized, Double-Blind, Placebo-Controlled Study Investigating the Safety And Efficacy of a Herbal Formulation on Knee Joint Function in Adults with Knee Osteoarthritis
    Li, Li
    Wang, Yuanyuan
    Wang, Shanglong
    Zong, Jiancheng
    Zhang, Zengliang
    Zou, Shengcan
    Zhao, Zhen
    Cao, Yu
    Liu, Zimin
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2025, 31 (01): : 54 - 63
  • [23] Combining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial
    Robert J. Petrella
    Anthony Cogliano
    Joseph Decaria
    Clinical Rheumatology, 2008, 27 : 975 - 981
  • [24] Combining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial
    Petrella, Robert J.
    Cogliano, Anthony
    Decaria, Joseph
    CLINICAL RHEUMATOLOGY, 2008, 27 (08) : 975 - 981
  • [25] Is hyaluronate sodium effective in the management of knee osteoarthritis? A placebo-controlled double-blind study
    Kul-Panza, E.
    Berker, N.
    MINERVA MEDICA, 2010, 101 (02) : 63 - 72
  • [26] Magnetic pulse treatment for knee osteoarthritis: A randomised, double-blind, placebo-controlled study
    Pipitone, N
    Scott, DL
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (03) : 190 - 196
  • [27] Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
    Vela, Jonathan
    Dreyer, Lene
    Petersen, Kristian Kjaer
    Arendt-Nielsen, Lars
    Duch, Kirsten Skjaerbaek
    Kristensen, Salome
    PAIN, 2022, 163 (06) : 1206 - 1214
  • [28] Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study
    Karlapudi, Vasu
    Sunkara, Krishna Bhagavan
    Konda, Purna Rajeswari
    Sarma, Kadainti V.
    Rokkam, Meher Prasanna
    JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION, 2023, 42 (02): : 159 - 168
  • [29] Treatment of pain attributed to plantar fasciitis with botulinum toxin A: A short-term, randomized, placebo-controlled, double-blind study
    Babcock, MS
    Foster, L
    Pasquina, P
    Jabbari, B
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (09) : 649 - 654
  • [30] Efficacy and safety of an oral complementary medicine combination in people with symptomatic knee osteoarthritis: Protocol for the double-blind, randomized, placebo-controlled ATLAS trial
    Shahid, Arashi
    Liu, Xiaoqian
    Bracken, Karen
    Christensen, Robin
    Deveza, Leticia Alle
    Collins, Simone
    Harnett, Joanna
    Hunter, David J.
    Mclachlan, Andrew J.
    Robbins, Sarah
    Bowden, Jocelyn L.
    OSTEOARTHRITIS AND CARTILAGE OPEN, 2024, 6 (04):